Dublin, July 04, 2024 (GLOBE NEWSWIRE) -- The "Synthetic Immunology Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.
World revenue for the Synthetic Immunology Market is set to surpass US$19 billion in 2024, with strong revenue growth through to 2034.
Advancements in Biotechnology Driving Market Growth
Technological advancements in synthetic biology, gene editing, and immunotherapy have revolutionized the landscape of healthcare, particularly in the emerging field of synthetic immunology. Synthetic biology techniques provide researchers with unprecedented control over the design and construction of biological molecules, allowing for the creation of novel synthetic molecules tailored to specific therapeutic needs. Biopharmaceuticals are leading the charge within the industry, capturing over 41% of the market revenue in 2023.
Biologics are surpassing traditional drugs in terms of new drug approvals by the FDA. By engineering synthetic antibodies, cytokines, and receptors, researchers can precisely target immune cells, pathways, or disease antigens with enhanced efficacy and specificity. Gene editing technologies, such as CRISPR-Cas9, enable researchers to modify the genetic code of immune cells, such as T cells, to enhance their ability to recognize and eliminate diseased cells. This targeted approach minimizes off-target effects and improves the overall effectiveness of immunotherapies.
High Development Costs of Synthetic Immunology Likely to Hamper Industry Growth
The development of synthetic immunotherapy and diagnostic tools entails significant investment in research and development (R&D) across multiple stages, from early discovery to clinical testing and regulatory approval. One of the primary cost drivers is the need for cutting-edge technology and expertise to design, engineer, and produce synthetic molecules with the desired therapeutic or diagnostic properties. This includes investment in sophisticated laboratory equipment, computational tools, and specialized personnel skilled in synthetic biology, gene editing, and immunology.
Moreover, conducting clinical trials to evaluate the safety and efficacy of synthetic immunotherapy and diagnostic products represents a substantial portion of R&D costs. Clinical trials require extensive resources, including patient recruitment, data collection and analysis, and compliance with regulatory standards for Good Clinical Practice (GCP).
Key Market Dynamics
Market Driving Factors
- Advancements in Biotechnology
- Increasing Prevalence of Chronic Diseases
- Rapid Growth in Cancer Immunotherapy
Market Restraining Factors
- High Development Costs of Synthetic Immunology
- Challenges in Regulatory Process
- Ethical Considerations of Synthetic Immunology
Market Opportunities
- Growing Demand of Personalized Medicine
- Emerging Therapeutic Areas
- Growing Synthetic Vaccine Development
Key Questions Answered
- How is the synthetic immunology market evolving?
- What is driving and restraining the synthetic immunology market?
- How will each synthetic immunology submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2034?
- How will the market shares for each synthetic immunology submarket develop from 2024 to 2034?
- What will be the main driver for the overall market from 2024 to 2034?
- Will leading synthetic immunology markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
- How will the market shares of the national markets change by 2034 and which geographical region will lead the market in 2034?
- Who are the leading players and what are their prospects over the forecast period?
- What are the synthetic immunology projects for these leading companies?
- How will the industry evolve during the period between 2024 and 2034? What are the implications of synthetic immunology projects taking place now and over the next 10 years?
- Is there a greater need for product commercialisation to further scale the synthetic immunology market?
- Where is the synthetic immunology market heading and how can you ensure you are at the forefront of the market?
- What are the best investment options for new product and service lines?
- What are the key prospects for moving companies into a new growth path and C-suite?
Forecasts to 2034 and other analyses reveal commercial prospects
- In addition to revenue forecasting to 2034, the new study provides you with recent results, growth rates, and market shares.
- You will find original analyses, with business outlooks and developments.
- Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, Porter's Five Forces Analysis, PEST Analysis and recent developments.
Market Segments Covered in the Report
Type
- Synthetic Antibodies
- Synthetic Vaccines
- Synthetic Adjuvants
- Synthetic Immunomodulators
- Others
Application
- Infectious Diseases
- Autoimmune Diseases
- Cancer
- Allergies
- Others
End-users
- Hospitals
- Clinics
- Research Institutes
- Others
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 20 leading national markets.
The report also includes profiles and for some of the leading companies in the Synthetic Immunology Market, with a focus on this segment of these companies' operations.
Leading companies profiled in the report
- ADC Therapeutics
- BioNTech SE
- Camena Bioscience
- CRISPR Therapeutics
- Editas Medicine
- Evonetix
- GenScript Biotech
- Ginkgo Bioworks
- Inscripta, Inc.
- Mammoth Biosciences
- Mission Therapeutics
- Moderna, Inc.
- Sherlock Biosciences
- Synlogic Therapeutics
- Synthego
The report provides you with the following knowledge:
- Revenue forecasts to 2034 for the Synthetic Immunology Market, with forecasts for type, application, end-users, each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
- Revenue forecasts to 2034 for five regional and 24 key national markets.
- Prospects for established firms and those seeking to enter the market - including company profiles for 15 of the major companies involved in the Synthetic Immunology Market.
For more information about this report visit https://www.researchandmarkets.com/r/qw42x
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
